Journal of Cardiac Failure
Volume 16, Issue 9 , Pages 734-741 , September 2010

Cost-Effectiveness of Implantable Cardioverter-Defibrillators in Children With Dilated Cardiomyopathy

  • Brian Feingold, MD, MS

      Affiliations

    • Division of Pediatric Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
    • Corresponding Author InformationReprint requests: Brian Feingold, MD, MS, Children's Hospital of Pittsburgh of UPMC, Division of Pediatric Cardiology, 4401 Penn Avenue, 5th Floor, Faculty Pavilion, Pittsburgh, PA 15224. Tel: (412) 692-5541; Fax: (412) 692-6991.
    • ,
  • Gaurav Arora, MD

      Affiliations

    • Division of Pediatric Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
    • ,
  • Steven A. Webber, MBChB

      Affiliations

    • Division of Pediatric Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
    • ,
  • Kenneth J. Smith, MD, MS

      Affiliations

    • Section of Decision Sciences and Clinical Systems Modeling, Department of Medicine, University of Pittsburgh, Pittsburgh, PA

Received 18 January 2010 ,Revised 2 April 2010 ,Accepted 26 April 2010.

References 

  1. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002;105:1453–1458
  2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  3. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569–1575
  4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882–1890
  6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–2158
  7. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933–1940
  8. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  9. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114:135–142
  10. Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, et al. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med. 2001;135:870–883
  11. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353:1471–1480
  12. Dubin AM, Berul CI, Bevilacqua LM, Collins KK, Etheridge SP, Fenrich AL, et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J Card Fail. 2003;9:375–379
  13. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–1691
  14. Silka MJ, Bar-Cohen Y. Pacemakers and implantable cardioverter-defibrillators in pediatric patients. Heart Rhythm. 2006;3:1360–1366
  15. Drummond MF, Schulpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed.. Oxford: Oxford University Press; 2005;
  16. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276:1253–1258
  17. Rhee EK, Canter CE, Basile S, Webber SA, Naftel DC. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?. J Heart Lung Transplant. 2007;26:447–452
  18. Kirklin JK, Naftel DC, Caldwell RL, Pearce FB, Bartlett H, Rusconi P, et al. Should status II patients be removed from the pediatric heart transplant waiting list? A multi-institutional study. J Heart Lung Transplant. 2006;25:271–275
  19. Morrow RW, Kirklin JK. Survival after pediatric heart transplantation. In:  Canter CE,  Kirklin JK editor. ISHLT monograph series 2: pediatric heart transplantation. Vol 2. Philadelphia, PA: Elsevier; 2007;p. 123–137
  20. Gabry MD, Brodman R, Johnston D, Frame R, Kim SG, Waspe LE, et al. Automatic implantable cardioverter-defibrillator: patient survival, battery longevity and shock delivery analysis. J Am Coll Cardiol. 1987;9:1349–1356
  21. Hauser RG. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol. 2005;45:2022–2025
  22. Measuring Worth. http://www.measuringworth.com. July 10-25, 2008.
  23. Dayton JD, Kanter KR, Vincent RN, Mahle WT. Cost-effectiveness of pediatric heart transplantation. J Heart Lung Transplant. 2006;25:409–415
  24. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89–102
  25. Pollock-BarZiv SM, Anthony SJ, Niedra R, Dipchand AI, West LJ. Quality of life and function following cardiac transplantation in adolescents. Transplant Proc. 2003;35:2468–2470
  26. Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br J Health Psychol. 2003;8:165–178
  27. DeMaso DR, Lauretti A, Spieth L, van der Feen JR, Jay KS, Gauvreau K, et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol. 2004;93:582–587
  28. Dubin AM, Batsford WP, Lewis RJ, Rosenfeld LE. Quality-of-life in patients receiving implantable cardioverter defibrillators at or before age 40. Pacing Clin Electrophysiol. 1996;19:1555–1559
  29. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144:282–289
  30. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. 2008;359:999–1008
  31. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, et al. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007;45:377–385
  32. Vitale MB, Funk M. Quality of life in younger persons with an implantable cardioverter defibrillator. Dimens Crit Care Nurs. 1995;14:100–111
  33. Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20:332–342
  34. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia—AMIOVIRT. J Am Coll Cardiol. 2003;41:1707–1712
  35. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med. 2003;138:445–452
  36. Nugent AW, Daubeney PEF, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–1646
  37. Lotfi K, White L, Rea T, Cobb L, Copass M, Yin L, et al. Cardiac arrest in schools. Circulation. 2007;116:1374–1379
  38. Silka MJ. Implantable cardioverter-defibrillators in children. A perspective on current and future uses. J Electrocardiol. 1996;29(Suppl):223–225
  39. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004;15:72–76
  40. Chatrath R, Porter C-bJ, Ackerman MJ. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc. 2002;77:226–231
  41. Gradaus R, Wollmann C, Kobe J, Hammel D, Kotthoff S, Block M, et al. Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents. Heart. 2004;90:328–329
  42. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:924–932
  43. Silka MJ, Kron J, Dunnigan A, Dick M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation. 1993;87:800–807
  44. Stefanelli CB, Bradley DJ, Leroy S, Dick M, Serwer GA, Fischbach PS. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol. 2002;6:235–244
  45. Link MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK, et al. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol. 1999;15(83):263–266
  46. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589–594
  47. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22:1305–1313
  48. Sears SF, Conti JB. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am J Cardiol. 2006;98:565–567
  49. Red book. Montvale, NJ: Thomson Reuters, 2005.
  50. Dipchand AI, Naftel DC, Feingold B, Spicer R, Yung D, Kaufman B, et al. Outcomes of Children with Cardiomyopathy Listed for Transplant: a multi-institutional study. J Heart Lung Transplant. 2009;28:1312–1321

 Supported by an NIH / National Heart, Lung and Blood Institute Specialized Centers of Clinically Oriented Research (SCCOR) Award (HL-074732).

 See page 739 for disclosure information.

PII: S1071-9164(10)00201-0

doi: 10.1016/j.cardfail.2010.04.009

Journal of Cardiac Failure
Volume 16, Issue 9 , Pages 734-741 , September 2010

Article Tools

* Image Usage & Resolution